A high expression of FTO is detected in tumor tissue and is clinically related to the pathological traits of bladder cancer, suggesting that FTO is a potential biomarker for either the diagnosis or clinical prediction of bladder cancer. This evidence concerns the gene FTO and urinary bladder carcinoma.